Prolupin GmbH secured financing from the European Circular Bioeconomy Fund and other investors to accelerate growth and expand its plant-based product offerings in the European market.
Information on the Target
Prolupin GmbH, founded in 2015, has rapidly established itself in the plant-based food market with its vegan brand, Made with LUVE. The company's focus on lupine-based products has allowed it to experience significant annual growth, positioning Prolupin as a notable player in the bioeconomy sector. With this new round of financing, the company aims to tap into the mass market, facilitating further growth and international expansion.
Industry Overview in the Target’s Specific Country
The European plant-based food industry has been witnessing robust growth, driven by increasing consumer demand for healthier and more sustainable food options. The shift towards veganism and flexitarian diets has created a fertile environment for companies like Prolupin, which focus on innovative and sustainable products. As a result, the overall market for plant-based foods is projected to continue expanding, significantly impacting traditional dairy and food sectors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Germany, in particular, has emerged as a leader in the European bioeconomy, being recognized for its advancements in sustainable agricultural practices and investments in green technologies. The German governm
Similar Deals
Q·CAPITAL VENTURES → fresh five* premiumfood Ltd.
2023
QC·VENTURES → fresh five* premiumfood GmbH
2023
Odewald KMU → Karl Schmidt GmbH
2023
Project A → WindStar Medical
2020
European Circular Bioeconomy Fund
invested in
Prolupin
in 2023
in a Growth Equity & Expansion Capital deal